According to Bristol-Myers Squibb's latest financial reports the company has $16.54 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $29.48 B | -5.25% |
2022-12-31 | $31.11 B | -13.58% |
2021-12-31 | $36.00 B | -4.95% |
2020-12-31 | $37.88 B | -26.72% |
2019-12-31 | $51.69 B | 265.95% |
2018-12-31 | $14.12 B | 19.25% |
2017-12-31 | $11.84 B | -27.53% |
2016-12-31 | $16.34 B | 13.33% |
2015-12-31 | $14.42 B | -3.73% |
2014-12-31 | $14.98 B | -1.66% |
2013-12-31 | $15.23 B | 11.72% |
2012-12-31 | $13.63 B | -14.05% |
2011-12-31 | $15.86 B | 1.46% |
2010-12-31 | $15.63 B | 5.77% |
2009-12-31 | $14.78 B | 21.11% |
2008-12-31 | $12.20 B | 15.58% |
2007-12-31 | $10.56 B | 5.72% |
2006-12-31 | $9.99 B | -10.86% |
2005-12-31 | $11.20 B | 9.86% |
2004-12-31 | $10.20 B | 4.25% |
2003-12-31 | $9.78 B | 11.76% |
2002-12-31 | $8.75 B | -3.52% |
2001-12-31 | $9.07 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $68.77 B | 315.60% | ๐บ๐ธ USA |
Novartis NVS | $39.75 B | 140.25% | ๐จ๐ญ Switzerland |
Pfizer PFE | $89.28 B | 439.57% | ๐บ๐ธ USA |
AbbVie ABBV | $10.39 B | -37.17% | ๐บ๐ธ USA |
Eli Lilly LLY | $10.86 B | -34.35% | ๐บ๐ธ USA |
Amgen AMGN | $6.23 B | -62.34% | ๐บ๐ธ USA |
Sanofi SNY | $82.20 B | 396.76% | ๐ซ๐ท France |
Biogen BIIB | $15.21 B | -8.07% | ๐บ๐ธ USA |
Merck MRK | $37.63 B | 127.43% | ๐บ๐ธ USA |
AstraZeneca AZN | $37.50 B | 126.62% | ๐ฌ๐ง UK |